Navigation

News

Your contact person

Manager PR & Communications Jan Phillip Denkers

Filter reset
Moving forward, the Omics Hub will continue to serve as a key resource for clinicians and clinical network partners in order to drive novel research and ultimately improve personalized oncology and the treatment of patients.
Moving forward, the Omics Hub will continue to serve as a key resource for clinicians and clinical network partners in order to drive novel research and ultimately improve personalized oncology and the treatment of patients. (Image: Screenshot/Discover Oncology)

Indivumed: New Publication in Discover Oncology

Indivumed GmbH announced the fourth research publication enabled by the Indivumed Omics Hub. An interface for members of the Indivumed Global Clinical Network, the Omics ...

Read more …
Hans Kuhn hands over responsibilities to his successors Mariela Aranda (left) and Julianna Shibao (right).
Hans Kuhn hands over responsibilities to his successors Mariela Aranda (left) and Julianna Shibao (right). (Picture: altona Diagnostics)

New management at altona Diagnostics in Argentina and Brazil

After more than six years at the helm of the Argentine and Brazilian subsidiaries of altona Diagnostics based in Buenos ...

Read more …
3D vector field of the collagen direction and degree of orientation obtained by SAXS-Tensor-Tomography (Picture: DESY)
3D vector field of the collagen direction and degree of orientation obtained by SAXS-Tensor-Tomography (Picture: DESY)

Deeper Insights in Breast Cancer Metastasis

A collaborative effort between researchers from DESY, the University Medical Center Hamburg-Eppendorf (UKE), ...

Read more …
Together with its partners, SurgMark is now preparing to conduct clinical studies in North America and Europe and is building its distribution network. (Picture: Gorodenkoff/Adobe Stock)
Together with its partners, SurgMark is now preparing to conduct clinical studies in North America and Europe and is building its distribution network. (Picture: Gorodenkoff/Adobe Stock)

SurgMark: FDA 510(k) Clearance for SchurSign Tissue Marker

In January SurgMark GmbH announced that the U.S. Food & Drug Administration (FDA) has issued a 510(k) premarket notification for ...

Read more …
The Stentrode™ Endovascular Electrode Array (Photo: Synchron)
The Stentrode™ Endovascular Electrode Array (Photo: Synchron)

Synchron Acquires Equity Stake in ACQUANDAS

Synchron, the brain-computer interface (BCI) company developing endovascular technology to restore functionality in patients with motor impairment, today announced the acquisition of an equity stake ...

Read more …
To illustrate the type of environments in which gold nanoparticles can be used, the nanoparticles approach densely packed regions of proteins. (Image: Ferdinand Otto, UHH)
To illustrate the type of environments in which gold nanoparticles can be used, the nanoparticles approach densely packed regions of proteins. (Image: Ferdinand Otto, UHH)

"Stealth Effect"

An experiment led by a team of DESY and Universität Hamburg scientists has discovered that gold nanoparticles can move through liquid ...

Read more …
Evotec has started the search for a permanent solution for the position of CEO.

Evotec announces CEO transition

Evotec SE announced that after close to 15 years of successful service, CEO Dr Werner Lanthaler has informed the company, that he will not continue ...

Read more …
Prof. Thomas Feurer, Copyright: private
Prof. Thomas Feurer, Copyright: private

European XFEL: New Chairman of the Management Board

Physicist Prof Thomas Feurer has assumed the role of the new Chairman of the European XFEL Management Board on 1 January. Hailing from the University ...

Read more …

The LSN year in snapshots

Dear Cluster stakeholders, dear LSN enthusiasts, we have searched through our photo archive and compiled a few highlights in pictures from the Life Science Nord ...

Read more …
Johanna Hakanpää, scientist in charge of beamline P11, in conversation with Serghei Glinca, founder and CEO of CrystalsFirst. ( Photo: DESY)
Johanna Hakanpää, scientist in charge of beamline P11, in conversation with Serghei Glinca, founder and CEO of CrystalsFirst. ( Photo: DESY)

Cooperation for faster drug discovery

The mutual project “LigandML” receives funding by the IFB Hamburg aiming to leverage experimental capabilities for better data quality paired ...

Read more …
Dr. Jürgen Walkenhorst is stepping down as Managing Director of LSN on December 31st, 2023. (Image: Inga Sommer PHOTOGRAPHIE)
Dr. Jürgen Walkenhorst is stepping down as Managing Director of LSN on December 31st, 2023. (Image: Inga Sommer PHOTOGRAPHIE)

Dr. Jürgen Walkenhorst is leaving Life Science Nord

Dr. Jürgen Walkenhorst has been LSN Managing Director since June 1st, 2022 and is leaving the cluster due to family reasons at the end of ...

Read more …
Onco AI-Med meeting at Indivumed: Dr. David Kerr, Nils Schumacher, Prof. Gerry Melino, Nina Gabelia, Dr. John Marshall, Dr. Takayuki Yoshino, Prof. Hartmut Juhl, Dr. Sun Young Rha, Dr. Jesus Garcia-Foncillas, Dr. Carlos Sampaio and Dr. David Gallagher (fr
Onco AI-Med meeting at Indivumed: Dr. David Kerr, Nils Schumacher, Prof. Gerry Melino, Nina Gabelia, Dr. John Marshall, Dr. Takayuki Yoshino, Prof. Hartmut Juhl, Dr. Sun Young Rha, Dr. Jesus Garcia-Foncillas, Dr. Carlos Sampaio and Dr. David Gallagher (from left to right) (Picture: Indivumed)

Indivumed Hosts Onco AI-Med Annual Board Meeting in Hamburg

Indivumed Therapeutics (“Indivumed”) welcomed members of the Oncology Alliance For Individualized Medicine (“Onco AI-Med”) to its global headquarters in Hamburg, ...

Read more …
Job board